Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pulmonology

Do I Need a Chest CT, Chest X-ray, or DLCO Test for COPD?

At a Glance

After COPD is confirmed with spirometry, chest X-rays, CT scans, and DLCO are usually used selectively—not for routine monitoring. Doctors may order them when symptoms worsen, another lung or heart problem is suspected, or treatment planning requires more detail.

Important: Seek emergency care immediately if you experience severe or rapidly worsening breathlessness, chest pain, blue or gray lips, confusion, fainting, or the inability to speak in full sentences. Do not wait for an outpatient appointment or a scheduled imaging test.

After a COPD diagnosis is confirmed with spirometry, chest X-rays, chest CT scans, and DLCO tests are not typically needed on a routine, scheduled basis just to monitor the disease [1] [2]. Spirometry remains the primary test to measure your airflow and track your lung function over time.

Instead, imaging and DLCO are “problem-solving” tests. Doctors order them when symptoms worsen, to look for complications, or to evaluate whether you are a candidate for specific treatments [3]. They do not replace spirometry, and a single CT or DLCO result does not determine your overall COPD stage.

Chest X-ray: The Initial Problem-Solver

A chest X-ray is often the first imaging test your doctor will consider if you experience a sudden worsening of symptoms (an exacerbation) or develop new chronic shortness of breath [4] [3]. However, it is not automatically required for every flare-up.

While an X-ray cannot diagnose COPD, it can look for selected problems that might be causing your symptoms, such as pneumonia or fluid in the lungs [5]. It is important to know that a normal chest X-ray does not rule out all dangerous causes of breathlessness, such as a blood clot (pulmonary embolism), early pneumonia, or a heart problem. Your doctor will use the X-ray alongside your physical exam, oxygen levels, and possibly blood tests or an electrocardiogram (ECG) to determine the next steps.

Chest CT Scan: Detailed Structural Views

A computed tomography (CT) scan provides detailed cross-sectional images of your lungs. A chest CT is highly useful for specific situations:

  • Evaluating Emphysema: A CT scan can clearly show the extent of emphysema (destruction of the lung’s tiny air sacs) and whether your lungs are hyperinflated [6].
  • Identifying Overlap Conditions: If you have a chronic, productive cough or frequent infections, a CT scan can check for bronchiectasis (widened, scarred airways that easily trap mucus), though other clinical assessments are also required for a diagnosis [7].
  • Planning Treatments: If your COPD is severe, a CT scan maps out your lung anatomy to see if you are a candidate for procedures like lung-volume reduction surgery or endobronchial valves (tiny one-way valves placed in the airways via a scope to reduce hyperinflation) [8].

Why aren’t CT scans automatic for monitoring?
Medical guidelines do not recommend regular, serial CT scans simply to monitor COPD progression [2] [3]. Frequent diagnostic CT scans expose you to radiation and often reveal incidental or indeterminate nodules (small spots on the lungs). While most of these spots are benign (harmless), finding them can cause anxiety and may require follow-up scans based on established guidelines to ensure they do not grow [9]. Your doctor will order a CT when the expected benefits of the information outweigh these risks.

Note on Lung Cancer Screening: While CTs aren’t used to monitor COPD itself, many people with COPD who have a substantial smoking history may qualify for a separate, routine low-dose CT lung cancer screening [9]. This is a specific screening program based on your age and smoking history, not a COPD monitoring test. Ask your doctor if you meet the criteria.

DLCO: Measuring Gas Transfer

DLCO (Diffusing Capacity of the Lungs for Carbon Monoxide) is an advanced breathing test often done in a pulmonary function lab. While standard spirometry measures how much air you can blow out, DLCO measures how well gases transfer from your lung’s air sacs into your bloodstream [10].

Your doctor might order a DLCO test to provide clues about:

  • Emphysema: Because emphysema destroys the tiny air sacs where gas exchange happens, a lower DLCO score can indicate its presence [11] [12].
  • Pulmonary Vascular Disease: A low DLCO can also point toward issues with the blood vessels between the heart and lungs, such as pulmonary hypertension (high blood pressure in the lungs) [13] [14].
  • Disproportionate Symptoms: If you feel incredibly short of breath but your spirometry does not show severe airflow limitation, a low DLCO may provide one clue to explain your exercise limitations [15].

DLCO is a nonspecific test—a low result cannot diagnose emphysema or pulmonary hypertension by itself, and further evaluation (like an echocardiogram) is often needed.

The Role of Anemia in DLCO Testing
The DLCO test relies on carbon monoxide binding to hemoglobin (the oxygen-carrying protein in your red blood cells). If you have anemia (low hemoglobin), there is less hemoglobin available to bind to the gas, which can artificially lower your DLCO score [16] [17]. Your doctor should account for your hemoglobin levels—usually from a recent blood test—when interpreting your DLCO results [18].

Summary of Tests

Test What It Looks For When It Is Used Key Limitations
Chest X-ray Broad overview for pneumonia, fluid, or collapsed lung Initial check for sudden, unexplained symptom worsening Uses radiation; cannot show fine details or rule out all serious conditions
Chest CT Detailed cross-sectional view of lung structure (emphysema, bronchiectasis) Unclear symptoms or treatment planning (e.g., valves) Uses more radiation; often finds harmless spots that require follow-up
DLCO How well gases transfer from lungs to the bloodstream Disproportionate shortness of breath or evaluating emphysema/blood vessels No radiation; nonspecific result that requires context (like hemoglobin) to interpret

Common questions in this guide

Are chest CT, chest X-ray, and DLCO tests routine after a COPD diagnosis?
Usually not. Once COPD has been confirmed with spirometry, doctors generally use spirometry to follow airflow and order imaging or DLCO when symptoms change, a complication is suspected, or treatment planning requires more information.
When might I need a chest X-ray for COPD symptoms?
A chest X-ray may be considered for sudden worsening or new persistent breathlessness, especially when pneumonia, fluid in the lungs, or another problem is possible. It is not required for every flare-up, and a normal result does not rule out a blood clot, early pneumonia, or a heart problem.
What can a chest CT show in someone with COPD?
A chest CT gives detailed pictures that can show emphysema, overinflated lungs, or bronchiectasis and can help plan treatments such as lung-volume reduction surgery or one-way airway valves. CT scans are not usually repeated just to monitor COPD because of radiation exposure and the possibility of finding harmless spots that need follow-up.
What does a DLCO test tell me about my COPD?
DLCO measures how well gases move from the air sacs in your lungs into your bloodstream. A low result can provide clues about emphysema or lung blood-vessel disease and may help explain severe breathlessness when spirometry is not severely abnormal, but it cannot diagnose a cause by itself.
Can anemia change my DLCO result?
Yes. DLCO depends on hemoglobin in red blood cells to bind the test gas, so anemia can make the result look lower than it otherwise would be. Your clinician should consider a recent hemoglobin level when interpreting the test.
Does a normal chest X-ray mean my COPD is stable?
No. A normal X-ray may not show every cause of breathlessness or subtle lung change, and it cannot by itself establish that COPD is stable. Your clinician will interpret it with your symptoms, examination, oxygen level, and other tests when needed.
Is low-dose CT lung cancer screening the same as a COPD CT scan?
No. Low-dose CT screening is a separate preventive program for some people based mainly on age and smoking history; it is not routine imaging to track COPD. Ask your clinician whether you meet the screening criteria.

Get notified when new evidence is published on chronic obstructive pulmonary disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    [COPD - Importance of Lung Function Testing for Diagnosis and Treatment].

    Windisch W, Criée CP

    Deutsche medizinische Wochenschrift (1946) 2018; (143(8)):593-596 doi:10.1055/s-0043-123846.

    PMID: 29649849
  2. 2

    Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

    Vogelmeier CF, Criner GJ, Martinez FJ, et al.

    American journal of respiratory and critical care medicine 2017; (195(5)):557-582 doi:10.1164/rccm.201701-0218PP.

    PMID: 28128970
  3. 3

    ACR Appropriateness Criteria® Chronic Dyspnea-Noncardiovascular Origin: 2024 Update.

    , Christensen JD, Harowicz M, et al.

    Journal of the American College of Radiology : JACR 2025; (22(5S)):S163-S176 doi:10.1016/j.jacr.2025.02.034.

    PMID: 40409875
  4. 4

    Acute exacerbation of COPD.

    Ko FW, Chan KP, Hui DS, et al.

    Respirology (Carlton, Vic.) 2016; (21(7)):1152-65 doi:10.1111/resp.12780.

    PMID: 27028990
  5. 5

    Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study.

    Titova E, Christensen A, Henriksen AH, et al.

    Chronic respiratory disease 2019; (16()):1479972318769762 doi:10.1177/1479972318769762.

    PMID: 29848051
  6. 6

    Lobar distribution of non-emphysematous gas trapping and lung hyperinflation in chronic obstructive pulmonary disease.

    Shima H, Tanabe N, Sato S, et al.

    Respiratory investigation 2020; (58(4)):246-254 doi:10.1016/j.resinv.2020.01.001.

    PMID: 32085990
  7. 7

    Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications.

    Alam MA, Mangapuram P, Fredrick FC, et al.

    Therapeutic advances in pulmonary and critical care medicine 2024; (19()):29768675241300808 doi:10.1177/29768675241300808.

    PMID: 39655338
  8. 8

    Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial.

    Davey C, Zoumot Z, Jordan S, et al.

    Lancet (London, England) 2015; (386(9998)):1066-73.

    PMID: 26116485
  9. 9

    [Early detection of lung cancer using computed tomography among patients with chronic obstructive pulmonary disease].

    Saldías P F, Díaz P JC, Rain M C, et al.

    Revista medica de Chile 2016; (144(2)):202-10.

    PMID: 27092675
  10. 10

    Can the measurement of pulmonary diffusing capacity for nitric oxide replace the measurement of pulmonary diffusing capacity for carbon monoxide?

    Zavorsky GS, van der Lee I

    Respiratory physiology & neurobiology 2017; (241()):9-16 doi:10.1016/j.resp.2016.11.008.

    PMID: 27884796
  11. 11

    Disproportionally Impaired Diffusion Capacity Relative to Airflow Limitation in COPD.

    Tanabe N, Rhee CK, Sato S, et al.

    COPD 2020; (17(6)):627-634 doi:10.1080/15412555.2020.1845639.

    PMID: 33222554
  12. 12

    Breakdown of lung framework and an increase in pores of Kohn as initial events of emphysema and a cause of reduction in diffusing capacity.

    Yoshikawa A, Sato S, Tanaka T, et al.

    International journal of chronic obstructive pulmonary disease 2016; (11()):2287-2294 doi:10.2147/COPD.S114281.

    PMID: 27695315
  13. 13

    Diffusing capacity in chronic obstructive pulmonary disease assessment: A meta-analysis.

    Ni Y, Yu Y, Dai R, Shi G

    Chronic respiratory disease 2021; (18()):14799731211056340 doi:10.1177/14799731211056340.

    PMID: 34855516
  14. 14

    Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD.

    Balasubramanian A, Kolb TM, Damico RL, et al.

    Chest 2020; (158(2)):722-734 doi:10.1016/j.chest.2020.02.047.

    PMID: 32184109
  15. 15

    Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.

    Elbehairy AF, O'Donnell CD, Abd Elhameed A, et al.

    Journal of applied physiology (Bethesda, Md. : 1985) 2019; (127(4)):1107-1116 doi:10.1152/japplphysiol.00341.2019.

    PMID: 31369329
  16. 16

    Isolated, reduced diffusing capacity for carbon monoxide in the population - relations to symptoms, smoking and comorbidities.

    Hamrefors V, Westerbergh J, Behndig A, et al.

    BMC pulmonary medicine 2026; (26(1)).

    PMID: 42675482
  17. 17

    Clinical, Functional, and Comorbid Characteristics of COPD Patients with Impaired Diffusing Capacity: A Cross-Sectional Study.

    Tang L, Jiang Y

    Journal of clinical medicine 2026; (15(10)) doi:10.3390/jcm15103861.

    PMID: 42194821
  18. 18

    Quantitative Vertebral Bone Density Seen on Chest CT in Chronic Obstructive Pulmonary Disease Patients: Association with Mortality in the Korean Obstructive Lung Disease Cohort.

    Hwang HJ, Lee SM, Seo JB, et al.

    Korean journal of radiology 2020; (21(7)):880-890 doi:10.3348/kjr.2019.0551.

    PMID: 32524788

This page is for informational purposes only and does not constitute medical advice about COPD testing. Your clinician should decide which test is appropriate based on your symptoms, examination, and medical history.